ARCHIVED 1. List of Drugs for Exceptional Importation and Sale [2020-07-15]
Notice to Reader:
This is an archived list. Please refer to the most current version of this list.
Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.
Supersedes: 2020-06-18
Date issued: 2020-06-29
Access archived versions of this list.
Drug or Class of Drug; Brand Name, Medicinal Ingredient(s) | Dosage Form, Strength, Route of Administration | Country of Origin and Identifying Code | Name of Importer | Batch Number | Date | Information to Support Safe Use Made Available by Importer |
---|---|---|---|---|---|---|
Propofol; Fresenius Propoven, Propofol | Emulsion for injection or infusion, 100mL vial - 20mg/mL (2%), Intravenous use |
Austria and Sweden, Inner vial label: M080395 Outer box label: M080396 Package leaflet: M080510 |
Fresenius Kabi Canada Ltd. | N/A | April 16, 2020 | Dear Healthcare Professional Letter |
Midazolam; Midazolam Injection, USP 2 mg / 2 mL (1 mg / mL), Midazolam |
Solution for injection, 1 mg/1 mL, Intravenous and intermuscular use |
USA, ANDA 203460 | Fresenius Kabi Canada Ltd. | N/A | April 17, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Ketamine; Ketamine Hydrochloride Injection USP 500mg/5mL, Ketamine Hydrochloride |
Solution - concentrate, 100mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2051-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Norepinephrine; Levophed Injection USP 4mg/4mL, Norepinephrine Bitartrate |
Solution - concentrate, 1mg/mL, Intravenous infusion following dilution |
United States, National Drug Code (NDC): 00409-3375-04 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 2mg/2mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-17 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 5mg/5mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 10mg/10mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 0409-2587-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Pancuronium; Pancuronium Bromide Injection USP 10mg/10mL, Pancuronium Bromide |
Solution, 1mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-4646-01 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Dexmedetomidine; Precedex injection 200mcg/2mL, Dexmedetomidine Hydrochloride |
Solution - concentrate, 100mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1638-02 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Dexmedetomidine; Precedex injection 400mcg/100mL, Dexmedetomidine Hydrochloride |
Solution, 4mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1660-10 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Succinylcholine Chloride; Quelicin Injection USP 200mg/10mL, Succinylcholine Chloride |
Solution, 20mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-6629-02 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Rocuronium; Rocuronium Bromide injection 100mg/10mL, Rocuronium Bromide |
Solution, 10mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-9558-10 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Vecuronium; Vecuronium Bromide for Injection 10mg, Vecuronium Bromide |
Powder for solution, Intravenous use only |
United States, National Drug Code (NDC): 00409-1632-01 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Rocuronium Bromide; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution (sterile), 50mg/5mL (10mg/mL), Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41, ANDA: 205656 |
SteriMax Inc. | N/A | May 1, 2020 | Dear Healthcare Professional Letter |
Salbutamol; Salbutamol Aldo-Union, Salbutamol sulfate |
Metered-Dose Aerosol, 100mcg per actuation, Inhalation |
Spain, National Health Care Reimbursement Number (NHRN): 797183.2 TLDO; M.A. No. 65.850 |
JAMP Pharma Corporation | N/A | May 7, 2020 | Dear Healthcare Professional Letter |
Azithromycin; Azithromycin for Injection USP, Azithromycin dihydrate |
Powder for solution, 500mg/vial, Intravenous use |
Canada, DIN: 02239952 |
SteriMax Inc. | 200570110 | May 7, 2020 | Canadian Product Monograph |
Fentanyl; Fentanyl Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 10ml ampoules, Intramuscular or intravenous use |
Malta, MA1207/00202 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Fentanyl; Fentanyl Citrate - Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 2ml ampoules, Intramuscular or intravenous use |
Latvia, 14-0232 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308716 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 10mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308718 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 15mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308715 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 5mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-006-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 4mg/mL Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-005-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-004-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Norepinephrine; Norepinephrine Bitartrate Injection, USP 4mg/4mL (1mg/mL), Norepinephrine Bitartate |
Injection, 1mg/mL, Intravenous use |
United States, National Drug Code (NDC): 36000-162-10 Product Code: AIN00610 |
Baxter Corporation | N/A | May 8, 2020 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-800-387-8399 Fax: 1-905-369-6560 |
Rocuronium; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution for injection (50mg/5mL), 10mg/mL, Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41 |
Laboratoire Riva Inc. | N/A | May 8, 2020 | Dear Healthcare Professional Letter |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 2mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201455.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 10mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201456.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 20mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201457.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 50mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201458.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Meropenem; Meropenem 1000 mg Powder for Solution for Injection or Infusion, Meropenem trihydrate |
Powder for solution, 1000mg, Intravenous use |
Ukraine, Ukraine Registration No. UA/17558/01/01, Manufacturing License No. G/28/1581 |
Strides Pharma Canada Inc. | N/A | May 12, 2020 | Contact Strides Pharma Canada at: 1565 Boulevard Lionel-Boulet, Varennes, QC J3X 1P2 Telephone: 1-514-731-2003 |
Timolol; Timo-Stulln, Timolol maleate |
Ophthalmic solution, 0.5%, Ophthalmic Use |
Germany, 06879051 |
Pharma Stulln Inc. |
N/A | May 15, 2020 | Contact Pharma Stulln at: 400-6500 TransCanada hwy., Pointe-Claire, QC H9R 0A5 Telephone: 1-833-278-8556 |
Salbutamol; Salbuhaler, Salbutamol sulfate |
Metered-Dose Aerosol, 100 mcg per actuation, Inhalation |
Philippines, DRP-3645 |
Sandoz Canada Inc. |
N/A | May 15, 2020 | Contact Sandoz Canada at : 110 de Lauzon, Boucherville, QC J4B 1E6 Telephone: 1-800-343-8839 |
Succinylcholine; Anectine, Succinylcholine Chloride |
Solution for injection, 200mg/10mL (20mg/mL), Intravenous use |
United States, National Drug Code (NDC) - Box: 0781-9053-95; Vial: 0781-9053-70 |
Sandoz Canada Inc. | N/A | May 20, 2020 | Contact Sandoz Canada at: 110 de Lauzon, Boucherville, QC J4B 1E6 Telephone: 1-800-343-8839 |
Midazolam; Sedozolam Solution for Injection or Infusion, Midazolam |
Solution, 5mg/5mL (1mg/1mL), Intravenous or intramuscular use |
Turkey, Register Number: 2016/246 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | June 9, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Midazolam; Sedozolam Solution for Injection or Infusion, Midazolam |
Solution, 15mg/3mL (5mg/1mL), Intravenous or intramuscular use |
Turkey, Register Number: 2016/290 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | June 9, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Cisatracurium; Cisatracurium Besylate Injection, Cisatracurium Besylate |
Solution for injection, 20mg/10ml (2mg/ml), Intravenous use |
United States, National Drug Code (NDC) – Inner label: 0781-3152-70; Outer label (box of 10): 0781-3152-95 |
Sandoz Canada Incorporated | N/A | June 15, 2020 | Contact Sandoz Canada at: 110 de Lauzon, Boucherville, QC J4B 1E6 Telephone: 1-800-343-8839 |
Propylthiouracil; PTU™, Propylthiouracil |
Tablet, 50mg, Oral use |
Australia, AUST R 13313 |
Phebra Canada Inc. | N/A | June 18, 2020 | Contact Phebra Canada Inc. at: medical@phebracanada.ca Phone: 1-866-333-5458 Fax: 1-514-667-526 |
Page details
- Date modified: